Pulmonary Arterial Hypertension: Combination Therapy in Practice

Marsha Burks; Simone Stickel; Nazzareno Galiè

Disclosures

Am J Cardiovasc Drugs. 2018;18(4):249-257. 

In This Article

Conclusion

As supported by long-term efficacy data[10–12] and the latest ESC/ERS guidelines,[2,3] combination therapy is now the mainstay of PAH management. Although combination therapy has the potential to be associated with practical challenges and additive side effects, these can be successfully managed in most cases. Specialist healthcare professionals in expert PAH centers possess the experience and expertise to allow the benefits of combination therapy to be maximized whilst reducing the risk to the patient.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....